SELLAS Life Sciences Group, Inc. (SLS)
SELLAS Life Sciences Group Market Cap: 537.01M for Dec. 31, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| GT Biopharma, Inc. | 8.352M |
| Geron Corp. | 842.63M |
| ADMA Biologics, Inc. | 4.341B |
| Lyell Immunopharma, Inc. | 455.79M |
| NovaBay Pharmaceuticals, Inc. | 710.70M |
Market Cap Related Metrics
| Price to Book Value | 11.77 |
| Price | 3.77 |
| Earnings Yield | -7.61% |